These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22408260)

  • 1. Regulation of acute graft-versus-host disease by microRNA-155.
    Ranganathan P; Heaphy CE; Costinean S; Stauffer N; Na C; Hamadani M; Santhanam R; Mao C; Taylor PA; Sandhu S; He G; Shana'ah A; Nuovo GJ; Lagana A; Cascione L; Obad S; Broom O; Kauppinen S; Byrd JC; Caligiuri M; Perrotti D; Hadley GA; Marcucci G; Devine SM; Blazar BR; Croce CM; Garzon R
    Blood; 2012 May; 119(20):4786-97. PubMed ID: 22408260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function.
    Zitzer NC; Snyder K; Meng X; Taylor PA; Efebera YA; Devine SM; Blazar BR; Garzon R; Ranganathan P
    J Immunol; 2018 Jun; 200(12):4170-4179. PubMed ID: 29720426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-181a Expression in Donor T Cells Modulates Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation.
    Lee CW; Wohlan K; Dallmann I; Förster R; Ganser A; Krueger A; Scherr M; Eder M; Koenecke C
    J Immunol; 2016 May; 196(9):3927-34. PubMed ID: 27009493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
    Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-153-3p, a new bio-target, is involved in the pathogenesis of acute graft-versus-host disease via inhibition of indoleamine- 2,3-dioxygenase.
    Zhao XS; Wang YN; Lv M; Kong Y; Luo HX; Ye XY; Wu Q; Zhao TF; Hu YH; Zhang HY; Huo MR; Wan J; Huang XJ
    Oncotarget; 2016 Jul; 7(30):48321-48334. PubMed ID: 27340781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-146a regulates the TRAF6/TNF-axis in donor T cells during GVHD.
    Stickel N; Prinz G; Pfeifer D; Hasselblatt P; Schmitt-Graeff A; Follo M; Thimme R; Finke J; Duyster J; Salzer U; Zeiser R
    Blood; 2014 Oct; 124(16):2586-95. PubMed ID: 25205119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ production.
    Sang W; Zhang C; Zhang D; Wang Y; Sun C; Niu M; Sun X; Zhou C; Zeng L; Pan B; Chen W; Yan D; Zhu F; Wu Q; Cao J; Zhao K; Chen C; Li Z; Li D; Loughran TP; Xu K
    Am J Hematol; 2015 Nov; 90(11):998-1007. PubMed ID: 26223969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease.
    Xiao B; Wang Y; Li W; Baker M; Guo J; Corbet K; Tsalik EL; Li QJ; Palmer SM; Woods CW; Li Z; Chao NJ; He YW
    Blood; 2013 Nov; 122(19):3365-75. PubMed ID: 24041574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Treatment with a miR-146a Mimic Suppresses Endotoxin Sensitivity and Partially Protects Mice from the Progression of Acute Graft-versus-Host Disease.
    Gartner JG; Durston MM; Booth SA; Ellison CA
    Scand J Immunol; 2017 Nov; 86(5):368-376. PubMed ID: 28853768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Aminolevulinic acid combined with sodium ferrous citrate (5-ALA/SFC) ameliorated liver injury in a murine acute graft-versus-host disease model by reducing inflammation responses through PGC1-α activation.
    Wang Z; Ma K; Liu C; Hu X; Que W; Ito H; Takahashi K; Nakajima M; Tanaka T; Ren K; Guo WZ; Yi SQ; Li XK
    Drug Discov Ther; 2021 Jan; 14(6):304-312. PubMed ID: 33390570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the miR-155 and protein prenylation feedback loop alleviated acute graft-versus-host disease through regulating the balance between T helper 17 and Treg cells.
    Wang X; Zhang R; Huang Z; Zang S; Wu Q; Xia L
    Transpl Immunol; 2021 Dec; 69():101461. PubMed ID: 34487810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum microRNA155 is increased in patients with acute graft-versus-host disease.
    Xie LN; Zhou F; Liu XM; Fang Y; Yu Z; Song NX; Kong FS
    Clin Transplant; 2014 Mar; 28(3):314-23. PubMed ID: 24494749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of acute graft-versus-host disease: from intestinal microbiota alterations to donor T cell activation.
    Zeiser R; Socié G; Blazar BR
    Br J Haematol; 2016 Oct; 175(2):191-207. PubMed ID: 27619472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation.
    Toubai T; Tanaka J; Nishihira J; Ohkawara T; Hirate D; Kondo N; Tone S; Shono Y; Ibata M; Sugita J; Kato N; Miura Y; Iwao N; Ota S; Imamura M
    Transpl Immunol; 2006 Aug; 16(2):117-24. PubMed ID: 16860715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.
    Sheng L; Mu Q; Wu X; Yang S; Zhu H; Wang J; Lai Y; Wu H; Sun Y; Hu Y; Fu H; Wang Y; Xu K; Sun Y; Zhang Y; Zhang P; Zhou M; Lai B; Xu Z; Gao M; Zhang Y; Ouyang G
    Front Immunol; 2020; 11():1534. PubMed ID: 32849519
    [No Abstract]   [Full Text] [Related]  

  • 16. MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice.
    Wu Y; Heinrichs J; Bastian D; Fu J; Nguyen H; Schutt S; Liu Y; Jin J; Liu C; Li QJ; Xia C; Yu XZ
    Blood; 2015 Sep; 126(11):1314-23. PubMed ID: 26138686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ex Vivo Treatment of Donor T Cells with Cosalane, an HIV Therapeutic and Small-Molecule Antagonist of CC-Chemokine Receptor 7, Separates Acute Graft-versus-Host Disease from Graft-versus-Leukemia Responses in Murine Hematopoietic Stem Cell Transplantation Models.
    Fowler KA; Li K; Whitehurst CB; Bruce DW; Moorman NJ; Aubé J; Coghill JM
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1062-1074. PubMed ID: 30668984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of interleukin-18 in acute graft-versus-host disease in mice.
    Itoi H; Fujimori Y; Tsutsui H; Matsui K; Sugihara A; Terada N; Hada T; Kakishita E; Okamura H; Hara H; Nakanishi K
    Transplantation; 2004 Nov; 78(9):1245-50. PubMed ID: 15548959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR Binding.
    Ranganathan P; Ngankeu A; Zitzer NC; Leoncini P; Yu X; Casadei L; Challagundla K; Reichenbach DK; Garman S; Ruppert AS; Volinia S; Hofstetter J; Efebera YA; Devine SM; Blazar BR; Fabbri M; Garzon R
    J Immunol; 2017 Mar; 198(6):2500-2512. PubMed ID: 28159900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
    Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
    Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.